CA
NZ
UK
AU
IND
US
Owens Corning filed its quarterly report on Form 10-Q for the period ended June 30, 2026 with the U.S. Securities and Exchange Commission, disclosing second-quarter and first-half financial results including net sales, earnings from continuing and discontinued operations, and balance sheet data.
United Therapeutics Corporation filed its Form 10-Q for the quarterly period ended June 30, 2026, with the U.S. Securities and Exchange Commission on August 5, 2026, reporting net income of $333.0 million for the second quarter and $607.9 million for the first half of …
Recursion Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission for the quarterly period ended June 30, 2026, submitted on August 5, 2026.
CVS Health Corporation filed its quarterly report on Form 10-Q with the SEC on August 5, 2026, covering the three and six months ended June 30, 2026, disclosing revenue, earnings, and balance sheet data for the period.
Palmer Square Capital BDC Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026, with the U.S. Securities and Exchange Commission, reporting a net decrease in net assets from operations of $28,786,782 for the six months ended June 30, 2026.
NiSource Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 5, 2026, covering the quarterly period ended June 30, 2026.
Eos Energy Enterprises, Inc. filed its Quarterly Report on Form 10-Q for the period ended June 30, 2026, with the Securities and Exchange Commission on August 5, 2026, disclosing its unaudited condensed consolidated financial statements and related notes.
Flutter Entertainment plc filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 5, 2026, covering the period ended June 30, 2026.
Orthofix Medical Inc. filed a Form 8-K with the SEC on August 5, 2026, announcing the release of its financial results for the second quarter ended June 30, 2026, via a press release furnished as Exhibit 99.1.
Orthofix Medical Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended June 30, 2026, disclosing net sales, operating losses, and balance sheet data for the three and six months ended June 30, 2026.
Please wait processing your request...